Arthritis & Rheumatology最新文献

筛选
英文 中文
Secular trends in biologic prescribing for psoriasis and psoriatic arthritis, 2014‐2024 2014 - 2024年银屑病和银屑病关节炎生物处方的长期趋势
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-23 DOI: 10.1002/art.43198
Mahum Mirza, Jean W. Liew, Mike Putman, Shikha Singla
{"title":"Secular trends in biologic prescribing for psoriasis and psoriatic arthritis, 2014‐2024","authors":"Mahum Mirza, Jean W. Liew, Mike Putman, Shikha Singla","doi":"10.1002/art.43198","DOIUrl":"https://doi.org/10.1002/art.43198","url":null,"abstract":"","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"7 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143866705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subcutaneous Panniculitis‐like T‐cell Lymphoma 皮下膜炎样T细胞淋巴瘤
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-22 DOI: 10.1002/art.43197
Shae Chambers, Caitlyn N. Myrdal, Victoria P. Werth
{"title":"Subcutaneous Panniculitis‐like T‐cell Lymphoma","authors":"Shae Chambers, Caitlyn N. Myrdal, Victoria P. Werth","doi":"10.1002/art.43197","DOIUrl":"https://doi.org/10.1002/art.43197","url":null,"abstract":"","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"108 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143857472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subacromial bursitis with rice bodies as an initial solo presentation of rheumatoid arthritis 伴有米粒体的肩峰下滑囊炎是类风湿性关节炎的初次单独表现
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-20 DOI: 10.1002/art.43189
Takeshi Zoshima
{"title":"Subacromial bursitis with rice bodies as an initial solo presentation of rheumatoid arthritis","authors":"Takeshi Zoshima","doi":"10.1002/art.43189","DOIUrl":"https://doi.org/10.1002/art.43189","url":null,"abstract":"Click on the article title to read more.","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"45 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143853111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK-pot" study) 类风湿关节炎患者使用Janus激酶抑制剂治疗的主要不良心血管事件发生率与生物疾病改善抗风湿药物的比较:来自国际注册合作的数据(“JAK-pot”研究)
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-15 DOI: 10.1002/art.43188
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Denis Choquette, Catalin Codreanu, Daniela Di Giuseppe, Irini Flouri, Doreen Huschek, Kimme L Hyrich, Florenzo Iannone, Tore K Kvien, Burkhard F Leeb, Dan Nordström, Lucia Otero-Varela, Karel Pavelka, Manuel Pombo-Suarez, Ana Rodrigues, Ziga Rotar, Prodromos Sidiropoulos, Sella A Provan, Anja Strangfeld, Trokovic Nina, Jakub Zavada, Lianne Kearsley-Fleet, Delphine S Courvoisier, Axel Finckh, Kim Lauper
{"title":"Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease-modifying antirheumatic drugs: data from an international collaboration of registries (the \"JAK-pot\" study)","authors":"Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Denis Choquette, Catalin Codreanu, Daniela Di Giuseppe, Irini Flouri, Doreen Huschek, Kimme L Hyrich, Florenzo Iannone, Tore K Kvien, Burkhard F Leeb, Dan Nordström, Lucia Otero-Varela, Karel Pavelka, Manuel Pombo-Suarez, Ana Rodrigues, Ziga Rotar, Prodromos Sidiropoulos, Sella A Provan, Anja Strangfeld, Trokovic Nina, Jakub Zavada, Lianne Kearsley-Fleet, Delphine S Courvoisier, Axel Finckh, Kim Lauper","doi":"10.1002/art.43188","DOIUrl":"https://doi.org/10.1002/art.43188","url":null,"abstract":"To assess the incidence of major adverse cardiovascular events (MACE) in RA patients treated with JAKi, TNF-inhibitors (TNFi) or biologic Disease-Modifying Anti-Rheumatic Drugs with other modes of action (bDMARD-OMA) in a multi-country, real-world population.","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"183 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143832082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing Predictive Biomarkers in Limited Cutaneous Systemic Sclerosis: The Role of Type I Interferon Score and Gender Considerations 增强局限性皮肤系统性硬化症的预测性生物标志物:I型干扰素评分的作用和性别考虑
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-14 DOI: 10.1002/art.43187
Sheng Li
{"title":"Enhancing Predictive Biomarkers in Limited Cutaneous Systemic Sclerosis: The Role of Type I Interferon Score and Gender Considerations","authors":"Sheng Li","doi":"10.1002/art.43187","DOIUrl":"https://doi.org/10.1002/art.43187","url":null,"abstract":"Click on the article title to read more.","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"42 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143832084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-parametric profiling of circulating immune cells identifies an expansion of CD25hi switched memory B cells in Osteoarthritis 循环免疫细胞的多参数分析鉴定了骨关节炎中CD25hi开关记忆B细胞的扩增
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-14 DOI: 10.1002/art.43186
Neety Sahu, Yudhisthar Singh Bedi, Fiorella Grandi, William J. Maloney, Constance R. Chu, Nidhi Bhutani
{"title":"Multi-parametric profiling of circulating immune cells identifies an expansion of CD25hi switched memory B cells in Osteoarthritis","authors":"Neety Sahu, Yudhisthar Singh Bedi, Fiorella Grandi, William J. Maloney, Constance R. Chu, Nidhi Bhutani","doi":"10.1002/art.43186","DOIUrl":"https://doi.org/10.1002/art.43186","url":null,"abstract":"Osteoarthritis (OA) is a chronic, debilitating disease with no available disease-modifying drugs. Biomarker identification in OA patients has hitherto been limited to serum proteins and bulk epigenomic feature identification.","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"7 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143832083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Zimlovisertib, Ritlecitinib and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Zimlovisertib、Ritlecitinib和Tofacitinib单独或联合治疗中重度类风湿关节炎和甲氨蝶呤反应不足患者的疗效和安全性
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-14 DOI: 10.1002/art.43184
Spencer I. Danto, Mikhail Salganik, Anindita Banerjee, Pawel Hrycaj, Irina Jashi, Negin Shojaee, Ravi Shankar P. Singh, Steven A. Gilbert, Karen Page, Elena Peeva, Michael S. Vincent, Jean S. Beebe
{"title":"Efficacy and Safety of Zimlovisertib, Ritlecitinib and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate","authors":"Spencer I. Danto, Mikhail Salganik, Anindita Banerjee, Pawel Hrycaj, Irina Jashi, Negin Shojaee, Ravi Shankar P. Singh, Steven A. Gilbert, Karen Page, Elena Peeva, Michael S. Vincent, Jean S. Beebe","doi":"10.1002/art.43184","DOIUrl":"https://doi.org/10.1002/art.43184","url":null,"abstract":"To evaluate the efficacy and safety of zimlovisertib (interleukin-1 receptor-associated kinase 4 inhibitor) in combination with ritlecitinib (a Janus kinase [JAK] 3 and tyrosine kinase expressed in hepatocellular carcinoma [TEC] kinase family inhibitors) or tofacitinib (a JAK inhibitor) vs tofacitinib alone.","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"183 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143827306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time-dependent effect of prophylactic trimethoprim-sulfamethoxazole on the incidence of serious infections in ANCA-associated vasculitis: A target trial emulation study 预防性甲氧苄啶-磺胺甲恶唑对anca相关性血管炎严重感染发生率的时间依赖性影响:一项目标试验模拟研究
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-14 DOI: 10.1002/art.43185
Yun Kyu Kim, Jeffrey R Curtis, Se Rim Choi, Jina Yeo, Min Jung Kim, Yun Jong Lee, Eun Bong Lee, Jun Won Park
{"title":"Time-dependent effect of prophylactic trimethoprim-sulfamethoxazole on the incidence of serious infections in ANCA-associated vasculitis: A target trial emulation study","authors":"Yun Kyu Kim, Jeffrey R Curtis, Se Rim Choi, Jina Yeo, Min Jung Kim, Yun Jong Lee, Eun Bong Lee, Jun Won Park","doi":"10.1002/art.43185","DOIUrl":"https://doi.org/10.1002/art.43185","url":null,"abstract":"To investigate the effect of prophylactic trimethoprim-sulfamethoxazole (TMP-SMX) on the incidence of serious infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV).","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"121 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143832085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert perspective: How, When, and Why to Potentially Stop Anti-resorptive Drugs in Osteoporosis 专家观点:骨质疏松症患者如何、何时、为何停用抗再吸收药物
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-11 DOI: 10.1002/art.43179
Giovanni Adami, Kenneth G Saag
{"title":"Expert perspective: How, When, and Why to Potentially Stop Anti-resorptive Drugs in Osteoporosis","authors":"Giovanni Adami, Kenneth G Saag","doi":"10.1002/art.43179","DOIUrl":"https://doi.org/10.1002/art.43179","url":null,"abstract":"Osteoporosis is a chronic disease and anti-resorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used anti-resorptive treatments bisphosphonates and denosumab have short and longer term risks that, coupled with their benefits and other unique characteristics, influence consideration for at least periodic discontinuation. Bisphosphonates retain their effects even after discontinuation due to their prolonged skeletal retention, while denosumab discontinuation is associated with a rapid rebound in bone turnover and increased fracture risk. There is controversy about how, when, and why to potentially stop these agents. We discuss both permanent and temporary discontinuation of long-term treatment with bisphosphonates and denosumab. We focus on the reasons and timing for discontinuation, as well as strategies to mitigate future fracture risk.","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"128 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143820048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: Enhancing Predictive Biomarkers in Limited Cutaneous Systemic Sclerosis: The Role of Type I Interferon Score and Gender Considerations 答复增强局限性皮肤系统性硬化症的预测性生物标志物:I型干扰素评分的作用和性别因素
IF 13.3 1区 医学
Arthritis & Rheumatology Pub Date : 2025-04-11 DOI: 10.1002/art.43180
Stefano Di Donato, Christopher P. Denton, Francesco Del Galdo
{"title":"Reply to: Enhancing Predictive Biomarkers in Limited Cutaneous Systemic Sclerosis: The Role of Type I Interferon Score and Gender Considerations","authors":"Stefano Di Donato, Christopher P. Denton, Francesco Del Galdo","doi":"10.1002/art.43180","DOIUrl":"https://doi.org/10.1002/art.43180","url":null,"abstract":"","PeriodicalId":129,"journal":{"name":"Arthritis & Rheumatology","volume":"4 1","pages":""},"PeriodicalIF":13.3,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143819001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信